期刊文献+

强直性脊柱炎男性患者骨特异性碱性磷酸酶、骨钙素、尿Ⅰ型胶原C末端肽与骨密度的关系 被引量:4

Relationships between Serum Bone-specific Alkaline Phosphatase、Serum Osteocalcin、Urinary C-terminal Telopeptide Fragments of Type I Collagen and Bone Mineral Density in Men with Ankylosing Spondylitis
下载PDF
导出
摘要 目的通过测定强直性脊柱炎(AS)男性患者血清骨特异性碱性磷酸酶(BALP)、血清骨钙素(sOC)、尿Ⅰ型胶原C末端肽(CTX-Ⅰ)水平,以探讨与疾病活动性、骨密度(BMD)的关系。方法用ELISA方法测定35名AS患者血清BALP、sOC、尿CTX-Ⅰ;用双能X线吸收法(DEXA)测定腰椎正位(AP)L1-L4总体和股骨颈的BMD,根据Bath强直性脊柱炎疾病活动指数(BASDAI)对患者病情进行评分,并与70名健康者对照。结果AS患者尿CTX-Ⅰ水平显著高于对照组(P<0.05);直线相关显示,尿CTX-Ⅰ水平与股骨颈BMD呈负相关(r=-0.414,P<0.05),与BASDAI、C反应蛋白(CRP)呈正相关(r=0.445,P<0.05;r=0.491,P<0.01)。AS患者血清BALP、sOC水平与对照组无统计学意义,且与BMD、BASDAI无明显相关性。结论CTX-Ⅰ水平升高提示患者骨吸收增强、骨密度降低、疾病呈活动性。 Objective To determine the levels of serum bone-specific alkaline phosphatase (BALP), serum osteocalcin(sOC) ,urinary C-terminal telopeptide fragments of type I collagen( CTX- I ) in men with ankylosing spondylitis (AS) and to investigate their associations with disease activity, bone mineral density (BMD). Methods Serum BALP,sOC, urinary CTX- I were determined by enzyme-linked immunosorbent assay in 35 men with AS,areal BMD at the posteroanterior lumbar, spine (L1-4) and femoral neck using dual energy X-ray absorptiometry (DEXA). Bath AS Disease Activity Index (BASDAI) were evaluated. Levels of biochemical markers were compared with those of 70 age-matched healthy men. Results Patients with AS had significantly higher mean urinary CTX-I level than control subjects (P 〈 0. 05 ). Urinary CTX-I levels showed significantly inverse correlations with femoral neck BMD (r = - 0. 414, P = 0. 030) but not with spinal BMD. There were significantly positive correlations between urinary CTX-I levels and BASDAI (r = O. 445, P = 0. 016) as well as between urinary CTX-I and CRP levels (r= 0. 491 ,P = 0. 006). Mean serum BALP and osteocalcin levels did not differ between patients and controls and did not show any significant correlationswith BMD, BASDAI in men with AS. Conclusion Elevated CTX-I reflects bone resorption,loss of femoral BMD and disease activity.
作者 龚著新 张华
出处 《中国实用医药》 2009年第19期49-51,共3页 China Practical Medicine
关键词 强直性脊柱炎 骨密度 尿Ⅰ型胶原C末端肽 骨特异性碱性磷酸酶 骨钙素 Ankylosing spondylitis (AS) bone mineral density(BMD) urinary C-terminal telopeptide fragments of type I collagen( CTX- I ) serum bone-specific alkaline phosphatase(BALP) serum osteocalcin (sOC)
  • 相关文献

参考文献6

  • 1van der Linden S, van der Heijde D. Ankylosing spondylitis. In: Ruddy S, HarrisJR ED, Sledge CB, editors. Kelley' s text book of rheumatology. 6th edition. PhiladelPhia: W. B. Saunders Company,2001 : 1039-1054.
  • 2Meirelles ES, Borelli A, Camargo OP. Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 1999 : 18 (5) :364-368.
  • 3Maghraoui AE, Borderie D, Cherruau B, et al. Osteopomsis, body composition, and bone Turnover in ankylosing spondylitis. J Rheumatol. 1999 Oct:26(10) :2205-2209.
  • 4Vander Linden S, Valkenburg HA, Cats A.. Evaluation of diagnosis criteria for ankylosing spondylitis : a proposal for modification of New York criteria. Arthritis Rheum, 1984,27:361.
  • 5Garrett SL, Jenkinson TR, Whitelock HC, et al. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spandylitis Disease Activity Index ( BASDAI ). Rheumatology, 1994,21:2286-2291.
  • 6Kostenuik PJ. Osteoprotegerin and RANKL regulate bone resorption, density, geometry And strength. Curr OPin Pharmacol.2005 Dec : 5 (6) :618-62.

同被引文献26

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部